Press release
Acid Sphingomyelinase Deficiency Therapeutics Market Size was valued ~USD 120 Million in 2023, estimated DelveInsight
DelveInsight's "Acid sphingomyelinase deficiency Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the acid sphingomyelinase deficiency historical and forecasted epidemiology as well as the acid sphingomyelinase deficiency market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.Discover Key Insights into the Acid Sphingomyelinase Deficiency Market with DelveInsight's In-Depth Report @ Acid Sphingomyelinase Deficiency Market Size [https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Acid Sphingomyelinase Deficiency Market Report
* In December 2024:- Sanofi- A Prospective Observational Study to Assess the Long-term Safety and Immunogenicity of Olipudase Alfa Therapy During Routine Clinical Care in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency. Ancillary protocol-specified procedures to address the study objectives (eg, assessment of ADA) may be considered outside the standard of care for acid sphingomyelinase deficiency (ASMD), but the study methodology remains non-interventional, as the additional collection of data from participants will not dictate treatment.
* The global incidence is estimated to range from 0.4 to 0.6 cases per 100,000 newborns. These figures are likely underestimated, suggesting that the actual incidence may be higher.
* Acid sphingomyelinase deficiency impacts both males and females equally, showing no significant gender disparity in its prevalence.
* Patients with Niemann-Pick disease type A disease develop symptoms as early as age 3 months. Niemann-Pick disease type B has a variable age of presentation but frequently appears early in childhood, when hepatosplenomegaly is detected and symptoms of lung involvement may occur.
* The leading Acid Sphingomyelinase Deficiency Companies such as Sanofi Genzyme, Orphazyme, Takeda Pharmaceutical, Actelion Pharmaceuticals , and others.
* Promising Acid Sphingomyelinase Deficiency Therapies such as Olipudase alfa/GZ402665/ Recombinant human acid sphingomyelinase , and others.
Stay ahead in the Acid Sphingomyelinase Deficiency Therapeutics Market with DelveInsight's Strategic Report @ Acid Sphingomyelinase Deficiency Market Outlook [https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Acid Sphingomyelinase Deficiency Epidemiology Segmentation in the 7MM
* Total Diagnosed Cases of Acid Sphingomyelinase Deficiency
* Total Treated Cases of Acid Sphingomyelinase Deficiency
Download the report to understand which factors are driving Acid Sphingomyelinase Deficiency epidemiology trends @ Acid Sphingomyelinase Deficiency Prevalence [https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Acid Sphingomyelinase Deficiency Approved Drugs
XENPOZYME (olipudase alfa): Sanofi
XENPOZYME, a hydrolytic lysosomal sphingomyelin-specific enzyme replacement therapy, is designed to replace deficient or defective acid sphingomyelinase (ASM), an enzyme that allows for the breakdown of the lipid sphingomyelin. In individuals with acid sphingomyelinase deficiency, the deficiency in the ASM enzyme leads to sphingomyelin accumulation in various tissues. XENPOZYME is not expected to cross the blood-brain barrier or modulate CNS manifestations of acid sphingomyelinase deficiency. XENPOZYME has not been studied in patients with acid sphingomyelinase deficiency type A.
Acid Sphingomyelinase Deficiency Drugs Market Insights
Enzyme replacement therapy (ERT) for acid sphingomyelinase deficiency is a pivotal treatment that restores deficient sphingomyelinase enzyme activity, thereby mitigating the accumulation of sphingomyelin and alleviating disease symptoms. Administered via intravenous infusion, ERT has been shown to reduce hepatosplenomegaly, improve hematological parameters, and stabilize neurological functions. While effective, ERT requires ongoing administration and is associated with potential side effects such as infusion reactions and allergic responses. The current market includes FDA-approved therapies like olipudase alfa, and research continues to refine treatment protocols and explore combination strategies to enhance patient outcomes and manage long-term treatment challenges.
Get In-Depth Knowledge on Acid Sphingomyelinase Deficiency Market Trends and Forecasts with DelveInsight @ Acid Sphingomyelinase Deficiency Treatment Market [https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Acid Sphingomyelinase Deficiency Market Outlook
The Acid sphingomyelinase deficiency therapeutics market remains in its early stages, with significant unmet needs and ongoing research efforts. The rarity of the disease and the high costs associated with drug development pose challenges, but the development of novel therapies and increasing awareness offer promising opportunities for addressing this complex condition. Continued investment in research and development, along with strategic collaborations, will be key to advancing treatment options and improving patient outcomes.
Scope of the Acid Sphingomyelinase Deficiency Market Report
* Study Period: 2020-2034
* Coverage: 7MM
* Acid Sphingomyelinase Deficiency Companies: Sanofi Genzyme, Orphazyme, Takeda Pharmaceutical, Actelion Pharmaceuticals, and Many Others.
* Acid Sphingomyelinase Deficiency Therapies- Olipudase alfa/GZ402665/ Recombinant human acid sphingomyelinase, and others.
* Acid Sphingomyelinase Deficiency Therapeutic Assessment: Acid Sphingomyelinase Deficiency current marketed and Acid Sphingomyelinase Deficiency emerging therapies
* Acid Sphingomyelinase Deficiency Market Dynamics: Acid Sphingomyelinase Deficiency market drivers and Acid Sphingomyelinase Deficiency market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Acid Sphingomyelinase Deficiency Unmet Needs, KOL's views, Analyst's views, Acid Sphingomyelinase Deficiency Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Acid Sphingomyelinase Deficiency Market Report @ Acid Sphingomyelinase Deficiency Market Drivers and Barriers [https://www.delveinsight.com/sample-request/acid-sphingomyelinase-deficiency-asmd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Key Insights
* Report Introduction
* Executive Summary of Acid Sphingomyelinase Deficiency (ASMD)
* Key Events
* ASMD Epidemiology and Market Forecast Methodology
* ASMD Market Overview at a Glance
* Disease Background and Overview: ASMD
* Treatment and Management
* Epidemiology and Patient Population of ASMD in the 7MM
* Patient Journey
* Marketed Therapies
* ASMD: Seven Major Market Analysis
* Unmet Needs
* SWOT Analysis
* KOL Views
* Market Access and Reimbursement
* Appendix
* DelveInsight Capabilities
* Disclaimer
* About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=acid-sphingomyelinase-deficiency-therapeutics-market-size-was-valued-usd-120-million-in-2023-estimated-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acid Sphingomyelinase Deficiency Therapeutics Market Size was valued ~USD 120 Million in 2023, estimated DelveInsight here
News-ID: 3781922 • Views: …
More Releases from ABNewswire

Navigating the Digital Landscape: Why IT Support is Crucial for Markham Business …
In today's fast-paced digital world, technology is the backbone of nearly every successful business. For companies in Markham, ensuring your IT infrastructure is robust, secure, and efficient is not just an advantage - it's a necessity. NetFusion Designs Inc. offers Markham IT Support to help businesses thrive in this competitive environment.
The Importance of Reliable IT Support
Imagine trying to run a race with a pebble in your shoe. That's what it…

Barrington Basement Remodeling: Unlock Home's Hidden Potential with NeatFix
At NeatFix LLC, we specialize in home remodeling services that bring your vision to life, turning dull, unused basements into functional and stylish areas you'll love.
When it comes to home remodeling in Barrington, basements are often the most overlooked spaces in a house. Yet, they hold immense potential to transform your home into something extraordinary. Whether you're looking to add more living space, increase your property value, or simply create…

Expert Roof Repair Services in Fort Collins: Pro Roofing America Delivers Reliab …
Pro Roofing America - Fort Collins Roofers has built a reputation for delivering top-notch roof repair service that combines expertise, quality materials, and a commitment to customer satisfaction. Whether it's a minor leak or significant storm damage, their team of skilled roofers is equipped to handle any challenge, ensuring homes remain safe and secure.
When it comes to maintaining the integrity of a home, few things are as critical as a…

Secrets to a Flawless Finish in Cabinet Painting
Cabinet painting is the secret to achieving a fresh, modern look without the hefty price tag of a full renovation. Whether you're updating a tired space or adding value to your home, a flawless finish in cabinet painting can completely elevate your interiors. In this post, we'll reveal the key steps to achieving professional-quality results, share tips from top cabinet painting services, and explain why partnering with the right painting…
More Releases for Acid
Chloroacetic Acid (Monochloroacetic Acid) Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Chloroacetic Acid (Monochloroacetic Acid) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Chloroacetic Acid (Monochloroacetic Acid) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Chloroacetic Acid (Monochloroacetic Acid)…
Bio-Based Platform Chemicals Market Value to Expand at $18.8 Billion by 2021 : I …
"North America and Europe, collectively accounted for more than half of the total platform chemicals market in 2015 and are expected to maintain this throughout the forecast period. Key factors responsible for the market growth in these regions include, stringent government regulations imposed on the consumption of toxic chemicals and rapid adoption of innovative technologies. However, Asia-Pacific is projected to be the fastest-growing segment due to increase in industrial activities…
pH Control/Salt Market by Region - North America, Latin America, Europe, Japan, …
According to Fact.MR’s recent forecast study, the global market for pH control/salts will register a value CAGR of 3.7% during the forecast period, 2017-2026. The report further reveals that by the end of 2026, more than 16,700,683 tons of pH control/salts will be sold across the globe.
Competition Tracking
Leading producers of pH control/salts have been profiled in the report. These include, Archer Daniels Midland Company, Batory Foods Inc., Brenntag Ingredients Inc.,…
pH Control/Salt Market by Region - North America, Latin America, Europe, Japan, …
According to Fact.MR’s recent forecast study, the global market for pH control/salts will register a value CAGR of 3.7% during the forecast period, 2017-2026. The report further reveals that by the end of 2026, more than 16,700,683 tons of pH control/salts will be sold across the globe.
Competition Tracking
Leading producers of pH control/salts have been profiled in the report. These include, Archer Daniels Midland Company, Batory Foods Inc., Brenntag Ingredients Inc.,…
Dimeric fatty acid Market, Dimeric fatty acid Market Growth, Dimeric fatty acid …
The Fact.MR report covers all the recent developments in the dimeric fatty acid market. The report features a list of market leaders and new entrants in the dimeric fatty acid market, including Croda International Plc., Kraton Corporation, Oleon NV, Shandong Huijin Chemical Co. Ltd., Liancheng Baixin Science and Technology Co. Ltd., Jiangsu Jinma Oil Technology Development Co., Ltd., Jiangsu Yonglin Oleochemical Co. Ltd., Anqing Hongyu Chemical Co., Ltd., Aturex Group,…
Feed Acid Market Report 2018: Segmentation by Type (Acetic Acid, Butyric Acid, F …
Global Feed Acid market research report provides company profile for Nutrex NV, Novozymes Adisseo France SAS, Pancosma SA, Perstorp Holding AB, BASF SE, Biomin GmbH, Kemin Industries Inc, Kemira Oyj, Novus International Inc and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…